NCT03771508 (SODA) is a clinical trial in Small Intestine Disease, sponsored by Medtronic - MITG.

Who is sponsoring NCT03771508?

NCT03771508 is sponsored by Medtronic - MITG.

What condition does NCT03771508 study?

NCT03771508 studies Small Intestine Disease, Small Intestine Cancer, Small Intestinal Ulcer Bleeding, Small Intestine Obstruction, Small Intestine Adenocarcinoma, Small Intestine Polyp.

Is NCT03771508 still recruiting?

NCT03771508 is currently completed. Last updated 27 October 2025.

Last reviewed 2025-10-27 · How we verify

NCT03771508: SODA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prospective Collection of PillCam SB3 Videos and Raw Data Files for Future Developments (SODA)

Completed Last updated 27 October 2025

What this trial tests

trial in Small Intestine Disease in 3,712 participants. Completed in 30 September 2025.

Timeline

13 December 2018

Primary endpoint
30 June 2025

30 September 2025

Quick facts

Lead sponsor	Medtronic - MITG
Status	Completed
Study type	OBSERVATIONAL
Enrollment	3,712
Start date	13 December 2018
Primary completion	30 June 2025
Estimated completion	30 September 2025
Sites	30 locations across United States

Conditions studied

Small Intestine Disease — all drugs for Small Intestine Disease →
Small Intestine Cancer — all drugs for Small Intestine Cancer →
Small Intestinal Ulcer Bleeding — all drugs for Small Intestinal Ulcer Bleeding →
Small Intestine Obstruction — all drugs for Small Intestine Obstruction →

Sponsor

Medtronic - MITG — full company profile →

Who can join

Eligibility, any sex, with Small Intestine Disease or Small Intestine Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Observational, Multicenter, Post-market, Minimal risk, Prospective data collection of PillCam SB3 videos (including PillCam reports) and raw data files and optional collection of Eneteroscopy reports

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Small Intestine Disease

Currently open trials in the same condition.

NCT06462352 — Multicenter Study Comparing AI-Based Navicam vs. Conventional Pillcam in Small Bowel Pathology · NA · recruiting

Other Medtronic - MITG trials

Trials by the same sponsor.

NCT07351071 — Post-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and Rectal Res · NA · recruiting
NCT07166341 — Accuracy Verification of the INVOS PM7100 · active not recruiting
NCT07201961 — Nellcor™ Abbreviated Sensor Additional Data Collection · completed
NCT06710795 — AFFIX: Post-market Study of MaxTack™ Motorized Fixation Device in Subjects Undergoing Ventral Hernia Repair · NA · active not recruiting
NCT06638073 — Continuous Connected Patient Care (CCPC), a Pilot Testing a Novel Device for Continuous Vitals Monitoring - Department o · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03771508 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medtronic - MITG
Last refreshed: 27 October 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03771508.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing